AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Viral Hepatitis

Scientific Advances in HIV and HCV To Be Examined Next Week at CROI 2016

croi2016logo

The 2016 Conference on Retroviruses and Opportunistic Infections (CROI) takes place next week in Boston, and AIDS.gov will be there. This annual scientific meeting brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related…

HepCure: Free Hepatitis C App Available for Patients and Providers to Connect and Cure

HepCure

The Centers for Disease Control and Prevention estimate that more than half of all people living with hepatitis C in the U.S. are unaware of their infection and only 9% have been successfully treated and cured, despite the availability of well-tolerated curative treatments for the past several years. A major priority of the Action Plan…

In Appreciation of Dr. Ron Valdiserri’s 27 Years of Federal Service

Dr. Mermin & Dr. Valdiserri

At the end of 2015, we bid farewell to Dr. Ron Valdiserri, who retired from an exemplary career in Federal service. Over many years, Ron played key roles in the Federal responses to HIV and viral hepatitis, most recently as Deputy Assistant Secretary for Health, Infectious Diseases, and the Director of the HHS Office of…

Enhancing the Lives of Americans Living With HIV/AIDS, and Fighting the HIV/AIDS Epidemic

whitehouse2016budget

Editor’s Note: President Obama released his Fiscal Year 2017 budget proposal today. The White House also issued this fact sheet to highlight the budget’s investment in domestic HIV/AIDS activities across federal departments and agencies. Meeting Our Greatest Challenges: The President’s Fiscal Year 2017 Budget Under the President’s leadership, we have turned our economy around and…

Califf, FDA top officials call for sweeping review of agency opioids policies

FDA

Editor’s Note: Reducing opioid misuse not only reduces deaths from overdose but is also key to reducing new HIV and viral hepatitis infections among persons who inject drugs. For more on the link between opioid misuse, HIV and viral hepatitis, see this CDC report. In response to the opioid abuse epidemic, today Dr. Robert Califf, the…

Register Today for Webinar on Viral Hepatitis: Opportunities for Faith-based Groups

hv_map

The HHS Center for Faith-based and Neighborhood Partnerships (Partnership Center) and the Office of HIV/AIDS and Infectious Disease Policy (OHAIDP) have re-scheduled their co-sponsored webinar on the important role of faith communities in the national response to viral hepatitis.  The webinar will introduce a new resource for faith-based groups, the Health Ministers Guide to Viral Hepatitis:…

Justice Department Settles with Alabama Moving Company Over Hepatitis-C Discrimination

Department of Justice seal

The Justice Department reached an agreement today with Kemper Moving Systems Inc., a Huntsville, Alabama, franchise of Two Men and a Truck, to resolve allegations that the moving company violated the Americans with Disabilities Act (ADA) when it refused service because of a customer’s Hepatitis-C. Under the terms of a two-year consent decree filed today…

FDA approves Zepatier for treatment of chronic hepatitis C genotypes 1 and 4

FDA

The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients. Hepatitis C is a viral disease that causes inflammation of the liver that can lead to diminished liver function or liver failure….